Trials / Recruiting
RecruitingNCT07053605
Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Northern Jiangsu People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, researchers examined the changes in related indicators such as immune function, splenic vein,proper hepatic artery, and portal venous hemodynamics following laparoscopic resection of a splenic artery aneurysm. We determined the changes in these patient-related indicators after surgical treatment and whether these changes could improve patient outcomes.
Detailed description
Patients with Splenic Artery Aneurysm were recruited in accordance with the research inclusion criteria, and their general demographic information was collected. After thorough preoperative preparation, the same surgical team performed laparoscopic resection of the splenic artery aneurysm. Postoperatively,the same nursing team provided standardized care. Subsequently, patients received a standardized postoperative treatment protocol, which included pharmacotherapy, additional therapeutic interventions, and follow-up visits. During the treatment period, routine blood tests,liver function tests, coagulation function,immune function, as well as the hemodynamics of the portal vein, proper hepatic artery, and splenic vein were monitored preoperatively and at 7 days, 1 month, 3 months, 6 months, and 12 months postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | laparoscopic resection of splenic artery aneurysm with preservation of spleen | The laparoscopic resection of splenic artery aneurysm with preservation of spleen is performed by the same surgical team. |
Timeline
- Start date
- 2025-06-23
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2025-07-08
- Last updated
- 2025-07-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07053605. Inclusion in this directory is not an endorsement.